#9 THERAPEUTICS
In drug delivery, nanoparticles have been used to improve drug safety and efficacy. One of the immediate benefits has been a reduction in the toxic side effects associated with earlier formulations. Doxil and Abraxane are both FDA-approved nanoparticle formulations that deliver highly toxic chemotherapeutics in a safer manner. They have both been widely adopted in the clinic and continue to be used to treat more types of cancer.
Pharmaceutical companies are now exploring the next generation of nanoparticle-based drugs, which have unique features such as the ability to dissolve and release the drug when they sense a tumor microenvironment.
